ALKS

Alkermes plc News Headlines

$45.18
*  
0.73
1.64%
Get ALKS Alerts
*Delayed - data as of Sep. 17, 2014  -  Find a broker to begin trading ALKS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Halozyme Falls on Phase II Study Halt - Analyst Blog
4/8/2014 12:10:01 PM - Zacks.com

Bristol-Myers Seeks FDA Approval for HCV Candidates - Analyst Blog
4/8/2014 11:40:01 AM - Zacks.com

FDA Target Date for Gilead's HCV Candidate - Analyst Blog
4/8/2014 11:30:01 AM - Zacks.com

Mid-Morning Market Update: Markets Mixed; A. Schulman Lifts Profit Outlook
4/8/2014 10:29:56 AM - Benzinga

RadNet Touches New 52-Week High - Analyst Blog
4/8/2014 10:26:01 AM - Zacks.com

Agios Pharmaceuticals (AGIO) Surges: Stock Moves 27.8% Higher - Tale of the Tape
4/8/2014 9:04:01 AM - Zacks.com

MannKind Slips on Afrezza Approval Delay - Analyst Blog
4/8/2014 8:52:01 AM - Zacks.com

Idenix Pharmaceuticals (IDIX) Jumps: Stock Up 12.4% - Tale of the Tape
4/8/2014 8:51:01 AM - Zacks.com

Puma Biotechnology (PBYI) in Focus: Stock Tumbles 18.3% - Tale of the Tape
4/8/2014 8:45:01 AM - Zacks.com

Sector Update: Healthcare Shares Higher Pre-Market; Alkermes up 11% on Phase 3 Trial Results
4/8/2014 8:40:48 AM - MT Newswires

Sector Update: Healthcare
4/8/2014 8:40:06 AM - MT Newswires

Amgen's Oncology Candidate Disappoints - Analyst Blog
4/7/2014 1:10:01 PM - Zacks.com

Glaxo and Amgen Terminate Agreement - Analyst Blog
4/4/2014 4:45:01 PM - Zacks.com

Response Genetics (RGDX) in Focus: Stock Up 18.3% - Tale of the Tape
4/4/2014 9:39:01 AM - Zacks.com

Weakness Seen in Kindred Biosciences (KIN): Stock Tumbles 9.0% - Tale of the Tape
4/4/2014 8:48:01 AM - Zacks.com

Encouraging Results on Gilead's Sovaldi - Analyst Blog
4/3/2014 4:55:01 PM - Zacks.com

Acceleron Pharma (XLRN) Jumps: Stock Up 13.2% - Tale of the Tape
4/3/2014 9:39:01 AM - Zacks.com

Celladon (CLDN) Jumps: Stock Up 5.9% - Tale of the Tape
4/1/2014 9:39:01 AM - Zacks.com

Momenta Pharmaceuticals Slumps: MNTA Falls 16.9% in Session - Tale of the Tape
4/1/2014 8:55:01 AM - Zacks.com

Exact Sciences (EXAS) Jumps: Stock Adds 10.2% in Session - Tale of the Tape
4/1/2014 8:51:01 AM - Zacks.com

Glaxo Presents Darapladib Data - Analyst Blog
3/31/2014 6:30:01 PM - Zacks.com

Idera Soars on Phase II Drug Data - Analyst Blog
3/31/2014 5:06:01 PM - Zacks.com

Alkermes Larger Than S&P 500 Component Joy Global
3/31/2014 4:40:42 PM - BNK Invest

Endocyte Prices New Offering at $21 Per Share - Analyst Blog
3/31/2014 4:30:01 PM - Zacks.com

FDA Nod for Biogen's Alprolix - Analyst Blog
3/31/2014 4:00:01 PM - Zacks.com